Cefoxitin clinical trials
How each study uses Cefoxitin is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Cefoxitin studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 18 Oct 1978 · MEFOXIN · NDA 050517 (FDA, Drugs@FDA)
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Name
- Cefoxitin
- 7
Studies by the year they started
7 studies that test it; most in 2016 (3); 1 more planned to start later
| Year | Studies |
|---|---|
| 2013 | 2 |
| 2016 | 3 |
| 2020 | 1 |
| 2025 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 0 · Other 8
The University of Queensland (2) · University of Michigan (1) · Poitiers University Hospital (1) · Assistance Publique - Hôpitaux de Paris (1) · Central Hospital, Nancy, France (1) · Yonsei University (1) · Hospital de Santa Maria, Portugal (1)
Often tested with
Tested in the same studies.
Clofazimine (2) · Amikacin (2) · Tigecycline (2) · Imipenem (2) · Sulbactam (1) · Amoxicillin (1) · Cilastatin (1) · Linezolid (1)
Studies
Open first, then newest update. How each study uses Cefoxitin is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 8
- Finding the Optimal Regimen for Mycobacterium Abscessus TreatmentRecruitingPhase 2/3The University of QueenslandNCT04310930Written as Cefoxitin
- Testing a Novel Combination Treatment (Arm D) Versus Standard of Care for Intensive Phase Treatment for Mycobacterium Abscessus Pulmonary Disease in People With or Without Cystic Fibrosis in the Finding the Optimal Regimen for Mycobacterium Abscessus Treatment (FORMaT) Adaptive Platform TrialNot yet recruitingPhase 2The University of QueenslandNCT07485010Written as Cefoxitin
- Precision Antibiotic Dosing for AppendectomyCompletedPhase 1University of MichiganNCT06860802Written as Cefoxitin
- Effectiveness of Prophylactic Antibiotics to Prevent Post Endoscopic Retrograde Cholangio Pancreatography Bacteremia in Biliary Obstruction PatientStatus unknownNot applicableYonsei UniversityNCT02958059Written as Pacetin® (cefoxitin)
- Efficacy and Pharmacokinetic/Pharmacodynamic Parameters of Cefoxitin in Women With Acute Pyelonephritis Without Severity Symptoms Due to Extended-spectrum β-lactamase Producing Escherichia ColiTerminatedNot applicableAssistance Publique - Hôpitaux de ParisNCT01820793Written as Cefoxitin
- Evaluation of the Non-inferiority of Cefoxitin Versus Imipenem/Cilastatin in the Treatment of Urinary Tract Infections Caused by ESBL-producing Escherichia ColiTerminatedPhase 4Central Hospital, Nancy, FranceNCT02474706Written as Cefoxitin
- Study of Repeated Cefoxitin Administration in Major Abdominal Surgery Using a Microdialysis TechniqueCompletedPhase 4Poitiers University HospitalNCT02703857Written as cefoxitin
- Immediate Versus Delayed Induction in Term-PROM Using or Not Antibiotic ProphylaxisStatus unknownNot applicableHospital de Santa Maria, PortugalNCT02985086Written as Cefoxitin
Given beside what is tested · 1 — Cefoxitin is usual care or a partner of the new treatment
As the comparator · 1 — what is tested is compared with Cefoxitin
Codes
What other systems call Cefoxitin · ClinicalTrials.gg INT007170
- MeSH (NLM) D002440CefoxitinConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 6OEV9DX57YCEFOXITINConfirmed FDA, NLM, Wikidata
- RxNorm 2189Confirmed FDA, Wikidata
- Wikidata Q2353907cefoxitinConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C61665CefoxitinOne source FDA
- DrugBank DB01331One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D002440 | Cefoxitin | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 6OEV9DX57Y | CEFOXITIN | Confirmed FDA, NLM, Wikidata |
| RxNorm | 2189 | — | Confirmed FDA, Wikidata |
| Wikidata | Q2353907 | cefoxitin | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C61665 | Cefoxitin | One source FDA |
| DrugBank | DB01331 | — | One source Wikidata |
Also registered as cefoxitin sodium (UNII Q68050H03T · RxNorm 203118).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.